CertificateBackground.png

Certificate of Completion

ErdosHorizontal.png

THIS ACKNOWLEDGES THAT

HAS COMPLETED THE SPRING 2022 DATA SCIENCE BOOT CAMP

Kriti Sehgal

clear.png

Roman Holowinsky, PhD

JUNE 08, 2022

DIRECTOR

DATE

TEAM

Pioneer

Asia Wyatt, Kriti Sehgal, Aziz Burak Guelen

clear.png

The clinical trial process is a multi-year, often decade-long process that involves rigorous research and testing from the petri dish to double-blind human tests. The overall cost to bring a single intervention to market can cost in the range of hundreds of millions of dollars to well over a billion dollars. Once a drug reaches the clinical trial stage, there are many factors that are taken into consideration for how to structure said trial–the age and number of participants, levels of masking, the location for the trial, etc.

While the goal is always to reach completion, there are a myriad of reasons why a clinical trial may be terminated or suspended. These can range from adverse side effects and poor safety to funding setbacks and lack of efficacy. The goal of our project is to determine which of these factors when structuring a clinical trial are the most important for cancer intervention trial completion and to predict whether or not a test set of trials will be completed.

Screen Shot 2022-06-03 at 11.31.35 AM.png
github URL